Evaluating outcomes of breast-conserving surgery for cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the outcomes of oncoplastic breast-conserving surgery (OPBCS) in patients with pre-invasive or invasive breast cancer. It focuses on developing and validating a standardized surgical assessment tool within a shared decision-making framework. The study will gather data on surgical outcomes, quality of life, and time-to-event outcomes, addressing the individualized nature of surgical decision-making in breast cancer treatment. By analyzing various factors such as tumor location and patient preferences, the study seeks to improve the standardization of surgical techniques.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Female aged above 18 years.
2. Signed and dated written informed consent before the start of specific protocol procedures; oral consent for the participants of the quality control retrospective cohort study before accepting to partake a telephone interview.
3. Patients with invasive breast cancer (IBC) or ductal cancer in situ (DCIS) or unclear lesions mandating surgical excision or benign lesions amenable for surgical resection with BCS.
4. ECOG performance status 0-2.

Exclusion Criteria

1. Life expectancy of less than 6 months
2. Non candidate for breast conservation
3. Inability to understand given information and give informed consent or undergo study procedures

Where it's running

• Westmead Breast Cancer Institute
  Sydney, Australia Recruiting
• Uppsala University Hospital
  Uppsala, Sweden Recruiting
• Royal Marsden Hospital
  London, United Kingdom Recruiting

Study contacts

• Principal investigator: Andreas Karakatsanis, MD, PhD — Uppsala University
• Study coordinator: Andreas U Karakatsanis, MD, PhD
• Email: andreas.karakatsanis@uu.se
• Phone: +46765864826

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ATUSA 3D automated breast ultrasound for suspicious breast lesions

  This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.

  Recruiting at 2 sites iSono Health, Inc. · Sacramento, California and 1 other locations · NCT07505797

• SBRT with intratumoural pembrolizumab before neoadjuvant chemotherapy for high-risk breast cancer

  This study will test whether a short course of focused radiation plus two injections of pembrolizumab into the tumor before chemotherapy helps people with high‑risk invasive breast cancer respond better to treatment.

  Recruiting Phase 2 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario and 1 other locations · NCT07188246

• Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients

  This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.

  Recruiting Phase 2 University of California, Davis · Sacramento, California · NCT06268665

• Exercise program to boost muscle mass in breast cancer survivors

  This study is testing two group exercise programs to see if they can help women who have finished breast cancer treatment build more muscle.

  Recruiting Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT06115486

• Understanding how tumor shrinkage predicts cancer response in early breast cancer patients

  This study tests if measuring how much breast tumors shrink during chemotherapy can help predict how well the treatment will work for women with early-stage breast cancer.

  Recruiting at 2 sites Phase 2 Baylor Breast Care Center · Houston, Texas and 1 other locations · NCT05020860

• Personalized breast cancer screening based on individual risk factors

  This study is testing a personalized breast cancer screening method for women over 40 to see if it works better than standard yearly mammograms by using individual health and genetic information.

  Recruiting at 9 sites University of California, San Francisco · Birmingham, Alabama and 10 other locations · NCT02620852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.